DeepMed Research

Jonsson Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.ucla.edu

Clinical Trials

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Phase 2

Recruiting

Conditions: Hormone Receptor Positive Breast Carcinoma
Stage III Breast Cancer
Invasive Breast Cancer
Stage II Breast Cancer
Stage IIA Breast Cancer
Early-stage Breast Cancer
Stage IIB Breast Cancer

Interventions: Drug: Anastrozole
Procedure: Therapeutic Conventional Surgery
Biological: Trastuzumab Deruxtecan

First Posted Date: 2020-09-17

Last Posted Date: 2023-11-07

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 88

Registration Number: NCT04553770

Locations: 🇺🇸
St. Joseph Heritage Healthcare, Fullerton, California, United States
🇺🇸
Cancer Blood and Specialty Clinic, Los Alamitos, California, United States
🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

and more 6 locations

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer

Phase 1

Recruiting

Conditions: Stage II Renal Cell Cancer
Stage I Renal Cell Cancer

Interventions: Procedure: Interstitial Radiation Therapy

First Posted Date: 2020-07-16

Last Posted Date: 2025-05-13

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 17

Registration Number: NCT04473781

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

Phase 2

Recruiting

Conditions: Recurrent Primary Peritoneal Carcinoma
Recurrent Endometrial Carcinoma
Recurrent Fallopian Tube Carcinoma
Recurrent Ovarian Carcinoma

Interventions: Drug: Abemaciclib
Drug: Anastrozole
Drug: Letrozole

First Posted Date: 2020-07-14

Last Posted Date: 2024-06-07

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 32

Registration Number: NCT04469764

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Phase 1

Recruiting

Conditions: Bladder Carcinoma
Cervical Carcinoma
Cholangiocarcinoma
Hematopoietic and Lymphoid Cell Neoplasm
Hepatocellular Carcinoma
Malignant Adrenal Gland Neoplasm
Malignant Brain Neoplasm
Malignant Pleural Neoplasm
Malignant Skin Neoplasm
Malignant Solid Neoplasm

Interventions: Procedure: Computed Tomography
Drug: Gallium Ga 68 FAPi-46
Procedure: Positron Emission Tomography
Radiation: 18F-FDG

First Posted Date: 2020-07-07

Last Posted Date: 2024-08-06

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT04459273

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI

Not Applicable

Terminated

Conditions: Malignant Brain Neoplasm

Interventions: Procedure: Arterial Spin Labeling Magnetic Resonance Imaging
Procedure: pH-Weighted amine CEST
Procedure: Oxygen-weighted SAGE-EPI

First Posted Date: 2020-07-07

Last Posted Date: 2022-05-10

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 8

Registration Number: NCT04460495

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

Early Phase 1

Recruiting

Conditions: Metastatic Sarcoma
Recurrent Sarcoma
Sarcoma

Interventions: Procedure: Computed Tomography
Drug: Gallium Ga 68 FAPi-46
Procedure: Positron Emission Tomography
Radiation: 18F-FDG

First Posted Date: 2020-07-07

Last Posted Date: 2024-07-05

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT04457258

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer

Phase 3

Terminated

Conditions: Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Stage II Prostate Cancer AJCC v8
Stage IIIC Prostate Cancer AJCC v8
Stage IIC Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8
Stage IIIA Prostate Cancer AJCC v8
Stage IIIB Prostate Cancer AJCC v8
Stage IIA Prostate Cancer AJCC v8
Stage IIB Prostate Cancer AJCC v8

Interventions: Procedure: Computed Tomography
Other: Fluorine F 18 DCFPyL
Procedure: Positron Emission Tomography
Radiation: Radiation Therapy

First Posted Date: 2020-07-07

Last Posted Date: 2023-01-17

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 54

Registration Number: NCT04457245

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation

Phase 1

Active, not recruiting

Conditions: Prostate Carcinoma
Recurrent Prostate Carcinoma
Metastatic Malignant Neoplasm in the Prostate Gland

Interventions: Procedure: Computed Tomography
Other: Gallium Ga 68 FAPi-46
Procedure: Positron Emission Tomography

First Posted Date: 2020-07-07

Last Posted Date: 2024-07-12

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT04457232

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

Not Applicable

Recruiting

Conditions: Obesity
Malignant Neoplasm

Interventions: Other: Interview
Other: Media Intervention
Other: Questionnaire Administration
Other: Scale Device
Behavioral: Telephone-Based Intervention
Other: Text Message

First Posted Date: 2020-07-01

Last Posted Date: 2025-05-13

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT04453072

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma

Not Applicable

Withdrawn

Conditions: Mesothelioma

Interventions: Procedure: Biospecimen Collection
Procedure: Cryosurgery

First Posted Date: 2020-06-12

Last Posted Date: 2021-06-14

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT04429204

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy